Dentsply Sirona Inc (XRAY) Peer Comparison
$9.22
$-0.21
(-2.23%)
As on 26-Oct-2026 16:00EDT
Market cap
$1,880 Mln
Revenue (TTM)
$3,643 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
3.4 %
Edit
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,880 | 12,800 | 11,233 | 11,600 | 10,422 |
Revenue ($ Mln) |
3,643 | 1,505 | 785 | 6,561 | 613 |
Net Profit ($ Mln) |
-546.00 | 160.59 | 41.54 | -578.00 | -188.05 |
Net Margin (%) |
-14.99 | 10.67 | 5.29 | -8.81 | -30.68 |
RoE (%) |
-40.52 | 10.86 | 1.97 | -10.33 | -28.10 |
Price to Earnings |
-- | 79.84 | 242.37 | -- | -- |
Price-To-Book |
1.38 | 8.22 | 4.41 | 1.77 | 13.27 |
Income Statement ($ Mln)
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
3,643.00 | 1,504.87 | 785.10 | 6,561.10 | 612.84 |
|
Cost of Revenue
|
1,839.00 | 483.98 | 384.30 | 4,473.00 | 127.96 |
|
Gross Profit
|
1,840.00 | 942.44 | 347.62 | 2,139.40 | 393.22 |
|
Operating Expenses
|
1,378.00 | 833.56 | 335.50 | 2,373.70 | 565.37 |
|
Operating Profit (EBIT)
|
426.00 | 187.34 | 65.30 | -285.60 | -80.49 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-347.00 | 203.83 | 52.15 | -472.00 | -192.83 |
|
Provision for Tax
|
200.00 | 43.24 | 10.61 | 106.00 | -4.79 |
|
Profit after Tax (Net Income)
|
-546.00 | 160.59 | 41.54 | -578.00 | -188.05 |
|
Minority Interest
|
1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 93.19 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,351.00 | 1,530.77 | 2,112.03 | 5,630.20 | 682.49 |
|
Minority Interest
|
1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
2,668.00 | 210.18 | 705.49 | 4,583.70 | 135.71 |
|
Current Liabilities
|
1,185.00 | 233.78 | 132.66 | 1,382.00 | 102.33 |
|
Total Liabilities
|
5,429.00 | 1,826.52 | 2,949.70 | 11,794.70 | 893.49 |
Assets ($ Mln)
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
3,276.00 | 630.60 | 1,749.63 | 9,133.70 | 404.74 |
|
Current Assets
|
1,928.00 | 1,344.12 | 1,200.55 | 2,462.20 | 515.78 |
|
Total Assets
|
5,429.00 | 1,826.52 | 2,949.70 | 11,794.70 | 893.49 |
|
Total Debt*
|
2,312.00 | 212.71 | 690.94 | 3,697.80 | 102.84 |
|
Net Current Assets
|
743.00 | 1,110.35 | 1,067.90 | 1,080.20 | 413.45 |
Cashflow ($ Mln)
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
235.00 | 238.66 | 117.42 | 623.80 | -46.34 |
|
Cash Flow from Investing Activities
|
-132.00 | -404.59 | -298.47 | -130.50 | -77.61 |
|
Cash from Financing Activities
|
-80.00 | 26.53 | -15.21 | -409.40 | 11.89 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-14.91 | 11.76 | 1.79 | -5.43 | -22.53 |
|
ROE (%)
|
-40.52 | 10.86 | 1.97 | -10.33 | -28.10 |
|
ROA (%)
|
-8.02 | 7.95 | 1.36 | -4.08 | -18.00 |
|
EBIT Margin (%)
|
-7.03 | 13.63 | 9.87 | -4.47 | -30.58 |
|
Net Margin (%)
|
-14.99 | 10.67 | 5.29 | -8.81 | -30.68 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.76 | 17.55 | 16.49 | -1.57 | 41.55 |
|
EBIT Growth (%)
|
75.02 | 17.49 | 920.78 | -129.16 | -116.42 |
|
Net Profit Growth (%)
|
42.47 | 8.72 | 400.42 | -184.08 | -102.66 |
|
EPS Growth (%)
|
41.75 | 8.12 | 394.30 | -184.11 | -96.88 |
|
Book Value Growth (%)
|
-31.48 | 17.33 | 2.16 | -9.82 | -12.65 |
Valuation Ratios
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-3.82 | 68.93 | 189.42 | -14.68 | -34.59 |
|
Price / Book Value
|
1.70 | 8.58 | 4.40 | 1.40 | 9.90 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-96.16 | 53.25 | 50.32 | 81.94 | -43.50 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.48 | 0.00 | 0.26 | 0.65 | 0.00 |
|
Short term debt to equity ratio
|
0.17 | 0.01 | 0.01 | 0.01 | 0.00 |
|
Current Ratio
|
1.63 | 5.75 | 9.05 | 1.78 | 5.04 |
|
Quick Ratio
|
1.07 | 3.86 | 7.64 | 1.18 | 4.46 |
|
Interest Coverage
|
-2.81 | 157.91 | 1.92 | -1.64 | -38.31 |
Operating Efficiency Ratios
| Dentsply Sirona Inc (XRAY) | Penumbra (PEN) | Repligen (RGEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
17.02 | 12.65 | 20.09 | 17.36 | 22.67 |
|
Asset Turnover
|
0.53 | 0.74 | 0.26 | 0.46 | 0.59 |
|
Receivable days
|
64.22 | 46.54 | 72.41 | 58.79 | 60.95 |
|
Inventory Days
|
119.70 | 331.92 | 146.53 | 64.13 | 193.84 |
|
Payable days
|
53.70 | 26.16 | 29.05 | 58.13 | 60.19 |
|
Cash Conversion Cycle
|
130.22 | 352.30 | 189.88 | 64.79 | 194.60 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
